Pharmacielo Ltd
OTC:PCLOF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pharmacielo Ltd
OTC:PCLOF
|
CA |
|
N
|
Norwest Energy NL
F:NUX
|
AU |
|
Parke Bancorp Inc
F:PAV
|
US |
|
Wishbone Gold PLC
F:7N6
|
GI |
|
K
|
Kure Technologies Inc
OTC:UBSBF
|
CA |
|
Bechtle AG
OTC:BECTY
|
DE |
|
T
|
ThreeD Capital Inc
F:B5K3
|
CA |
|
LifeSpeak Inc
F:81F
|
CA |
|
G
|
GBK Beteiligungen AG
SWB:GBQ
|
DE |
|
C
|
CASI Pharmaceuticals Inc
F:ENMN
|
US |
|
B
|
BAVARIA Industries Group AG
XBER:B8A
|
DE |
|
B
|
Bechtle AG
SWB:BC8
|
DE |
|
T
|
THG PLC
OTC:THGHY
|
UK |
|
V
|
Valmet Oyj
XMUN:2VO
|
FI |
|
Leopalace21 Corp
OTC:LEOPF
|
JP |
|
S
|
Sanford Ltd
OTC:SARDF
|
NZ |
|
Horizonte Minerals PLC
F:H5W0
|
UK |
|
Team Internet Group PLC
F:4CN
|
UK |
|
Kyoritsu Maintenance Co Ltd
F:648
|
JP |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PCLOF's stock price target?
Not Available
PCLOF does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Pharmacielo Ltd?
Projected CAGR
11%
Over the last 5 years, the compound annual growth rate for Revenue has been 38%. The projected CAGR for the next 4 years is 11%.
What is the Gross Profit forecast for Pharmacielo Ltd?
Projected CAGR
50%
The compound annual growth rate for Gross Profit over the next 4 years is 50%.